Fetal warfarin syndrome
Fetal Warfarin Syndrome
Fetal Warfarin Syndrome (pronounced: fee-tuhl war-fuh-rin sin-drohm), also known as Warfarin Embryopathy or Coumadin Embryopathy, is a rare disorder that occurs in infants born to mothers who have consumed the anticoagulant Warfarin during pregnancy.
Etymology
The term "Fetal Warfarin Syndrome" is derived from the drug Warfarin, which is the causative agent of the syndrome, and the word "fetal", referring to the fetus, the unborn offspring in the womb.
Definition
Fetal Warfarin Syndrome is characterized by a range of birth defects including nasal hypoplasia (underdeveloped nose), stippled epiphyses (small, round densities seen in the ends of long bones), and various other skeletal abnormalities. The syndrome is caused by the teratogenic effects of Warfarin when it is taken during pregnancy, particularly during the first trimester.
Related Terms
- Warfarin: An anticoagulant medication that is used to prevent blood clots. It is the causative agent of Fetal Warfarin Syndrome.
- Teratogen: Any agent that can disturb the development of an embryo or fetus, leading to birth defects.
- Nasal hypoplasia: A condition characterized by an underdeveloped nose.
- Stippled epiphyses: Small, round densities seen in the ends of long bones, often associated with certain genetic disorders.
See Also
External links
- Medical encyclopedia article on Fetal warfarin syndrome
- Wikipedia's article - Fetal warfarin syndrome
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski